Biomex GmbH, based in Heidelberg, is registered with the Mannheim local court under commercial register number 337813 and positions itself as a partner to the life-science and diagnostics industry. The company is specialized in providing human raw materials, focusing on blood and plasma collections, leukocyte donations and the procurement of tissue samples, which are collected in its own donation centers in Germany and Africa or obtained via cooperation partners. In addition, Biomex provides services such as validation of diagnostic tests and expanded its offering in 2023 by building an in-house biobank and further developing the processing and provision of proteins. As of 31 December 2023 the company employed 120 people, with an annual average of 116 employees.
Der Handel mit Produkten aller Art, insbesondere mit biologischen und biochemischen Produkten, Testsystemen und Laborgeräten sowie die Herstellung und der Vertrieb von Nahrungsergänzungsmitteln und ähnlichen Erzeugnissen soweit hierbei keine staatliche Genehmigung erforderlich ist sowie der Betrieb von Plasma-Spendezentren zur Herstellung von Blut und Blutprodukten, die nicht bei der Arzneimittelherstellung verwendet werden, sowie die Erbringung von Dienst- und Beratungsleistungen auf dem Gebiet der vorbezeichneten Tätigkeitsfelder.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 337813 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Oliver Bosnjak | Geschäftsführer(in) | Heidelberg |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 337813 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2023 | Rohergebnis€8.9M2 | €326,075 | €14,083,901 | — |
| 2022 | Rohergebnis€15M2 | €4,765,339 | €17,675,383 | — |
| 2021 | Rohergebnis€12.8M2 | €4,340,870 | €12,899,347 | — |
| 2020 | Rohergebnis€7.9M2 | €1,753,884 | €7,478,719 | — |
| 2019 | ≤ €12M1 | €908,201 | €6,485,723 | — |
| 2018 | — | — | €5,672,675 | — |
| 2017 | small company1 | €321,163 | €5,539,852 | — |
| 2016 | small company1 | €284,008 | €5,521,715 | — |
| 2015 | small company1 | €272,183 | €4,923,099 | — |
| 2014 | small company1 | €211,162 | €3,714,813 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 337813 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €4,951,999 | 88.5% |
| Depreciation | €575,211 | 10.3% |
| Interest & Similar | €71,083 | 1.3% |
